STAT Plus: Young boy dies in trial for Pfizer Duchenne gene therapy
The boy had received the therapy for Duchenne muscular dystrophy in a trial for boys aged 2 or 3. Pfizer is pausing its trial in older boys.
Cancel anytime.
Subscribe nowOur Picks
Our Picks
War on Recovery
War on Recovery